Delisting Determination, The Nasdaq Stock Market, LLC, December 27, 2023,
Impel Pharmaceuticals Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Impel Pharmaceuticals Inc., effective
at the opening of the trading session on January 8, 2024.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5450(b)(2)(A) and
5450(b)(2)(C). The Company was notified of the Staff determination
on October 10, 2023. On October 16, 2023, the Company exercised its
right to appeal the Staff determination to the Listing Qualifications
Hearings Panel (Panel) pursuant to Rule 5815. A hearing on the matter
was scheduled for December 14, 2023. On December 14, 2023, the Company
witdrew its appeal. The Company securities were suspended on December 18,
2023. The Staff determination to delist the Company securities
became final on December 18, 2023.